{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:52:18Z","timestamp":1740163938374,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01397"],"award-info":[{"award-number":["PI17\/01397"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009664","name":"Sociedad Espa\u00f1ola de Cardiolog\u00eda","doi-asserted-by":"publisher","award":["Proyectos de la FEC para Investigaci\u00f3n B\u00e1sica en Cardiolog\u00eda 2018"],"award-info":[{"award-number":["Proyectos de la FEC para Investigaci\u00f3n B\u00e1sica en Cardiolog\u00eda 2018"]}],"id":[{"id":"10.13039\/100009664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Succinate is enhanced during initial reperfusion in blood from the coronary sinus in ST-segment elevation myocardial infarction (STEMI) patients and in pigs submitted to transient coronary occlusion. Succinate levels might have a prognostic value, as they may correlate with edema volume or myocardial infarct size. However, blood from the coronary sinus is not routinely obtained in the CathLab. As succinate might be also increased in peripheral blood, we aimed to investigate whether peripheral plasma concentrations of succinate and other metabolites obtained during coronary revascularization correlate with edema volume or infarct size in STEMI patients. Plasma samples were obtained from peripheral blood within the first 10\u00a0min of revascularization in 102 STEMI patients included in the COMBAT-MI trial (initial TIMI 1) and from 9 additional patients with restituted coronary blood flow (TIMI 2). Metabolite concentrations were analyzed by <jats:sup>1<\/jats:sup>H-NMR. Succinate concentration averaged 0.069\u2009\u00b1\u20090.0073\u00a0mmol\/L in patients with TIMI flow\u2009\u2264\u20091 and was significantly increased in those with TIMI 2 at admission (0.141\u2009\u00b1\u20090.058\u00a0mmol\/L, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). However, regression analysis did not detect any significant correlation between most metabolite concentrations and infarct size, extent of edema or other cardiac magnetic resonance (CMR) variables. In conclusion, spontaneous reperfusion in TIMI 2 patients associates with enhanced succinate levels in peripheral blood, suggesting that succinate release increases overtime following reperfusion. However, early plasma levels of succinate and other metabolites obtained from peripheral blood does not correlate with the degree of irreversible injury or area at risk in STEMI patients, and cannot be considered as predictors of CMR variables.<\/jats:p><jats:p><jats:bold>Trial registration:<\/jats:bold> Registered at <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.clinicaltrials.gov\">www.clinicaltrials.gov<\/jats:ext-link> (NCT02404376) on 31\/03\/2015. EudraCT number: 2015-001000-58.<\/jats:p>","DOI":"10.1038\/s41598-023-34196-7","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T15:02:50Z","timestamp":1682607770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spontaneous reperfusion enhances succinate concentration in peripheral blood from stemi patients but its levels does not correlate with myocardial infarct size or area at risk"],"prefix":"10.1038","volume":"13","author":[{"given":"Marta","family":"Consegal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignasi","family":"Barba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Garc\u00eda del Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imanol","family":"Otaegui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 F.","family":"Rodr\u00edguez-Palomares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernat","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neus","family":"Bellera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Ojeda-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filipa","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria \u00c1ngeles","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Mir\u00f3-Casas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Sambola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Mar\u00eda","family":"Lid\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Ba\u00f1eras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Barrab\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisol","family":"Ruiz-Meana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Inserte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Ferreira-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rodr\u00edguez-Sinovas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"issue":"3","key":"34196_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/cvr\/cvv279","volume":"109","author":"L Valls-Lacalle","year":"2016","unstructured":"Valls-Lacalle, L. et al. Succinate dehydrogenase inhibition with malonate during reperfusion reduces infarct size by preventing mitochondrial permeability transition. Cardiovasc. Res. 109(3), 374\u2013384 (2016).","journal-title":"Cardiovasc. Res."},{"issue":"7527","key":"34196_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","volume":"515","author":"ET Chouchani","year":"2014","unstructured":"Chouchani, E. T. et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515(7527), 431\u2013435 (2014).","journal-title":"Nature"},{"issue":"17","key":"34196_CR3","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1016\/S0021-9258(18)99802-9","volume":"241","author":"ND Goldberg","year":"1966","unstructured":"Goldberg, N. D., Passonneau, J. V. & Lowry, O. H. Effects of changes in brain metabolism on the levels of citric acid cycle intermediates. J. Biol. Chem. 241(17), 3997\u20134003 (1966).","journal-title":"J. Biol. Chem."},{"key":"34196_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0065-2571(70)90028-2","volume":"8","author":"HA Krebs","year":"1970","unstructured":"Krebs, H. A. Rate control of the tricarboxylic acid cycle. Adv. Enzyme Regul. 8, 335\u2013353 (1970).","journal-title":"Adv. Enzyme Regul."},{"key":"34196_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007546","author":"M Kohlhauer","year":"2018","unstructured":"Kohlhauer, M. et al. Metabolomic profiling in acute ST\u2010segment\u2013elevation myocardial infarction identifies succinate as an early marker of human ischemia\u2013reperfusion injury. J. Am. Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.117.007546 (2018).","journal-title":"J. Am. Heart Assoc."},{"issue":"9","key":"34196_CR6","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1016\/j.celrep.2018.04.104","volume":"23","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. Accumulation of succinate in cardiac ischemia primarily occurs via canonical krebs cycle activity. Cell Rep. 23(9), 2617\u20132628 (2018).","journal-title":"Cell Rep."},{"issue":"4","key":"34196_CR7","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/cvr\/cvaa148","volume":"117","author":"HA Prag","year":"2020","unstructured":"Prag, H. A. et al. Mechanism of succinate efflux upon reperfusion of the ischaemic heart. Cardiovasc. Res. 117(4), 1188\u20131201. https:\/\/doi.org\/10.1093\/cvr\/cvaa148 (2020).","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"34196_CR8","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.3390\/ijms22084151","volume":"22","author":"M Consegal","year":"2021","unstructured":"Consegal, M. et al. Citric acid cycle metabolites predict infarct size in pigs submitted to transient coronary artery occlusion and treated with succinate dehydrogenase inhibitors or remote ischemic perconditioning. Int. J. Mol. Sci. 22(8), 4151 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"34196_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00395-021-00842-2","volume":"116","author":"B Garc\u00eda del Blanco","year":"2021","unstructured":"Garc\u00eda del Blanco, B. et al. Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI). Basic Res. Cardiol. 116(1), 4 (2021).","journal-title":"Basic Res. Cardiol."},{"issue":"1","key":"34196_CR10","doi-asserted-by":"publisher","first-page":"17838","DOI":"10.1038\/s41598-020-74880-6","volume":"10","author":"C Lema","year":"2020","unstructured":"Lema, C. et al. 1H NMR serum metabolomic profiling of patients at risk of cardiovascular diseases performing stress test. Sci. Rep. 10(1), 17838 (2020).","journal-title":"Sci. Rep."},{"issue":"1","key":"34196_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12933-021-01333-3","volume":"20","author":"FJ Osuna-Prieto","year":"2021","unstructured":"Osuna-Prieto, F. J. et al. Elevated plasma succinate levels are linked to higher cardiovascular disease risk factors in young adults. Cardiovasc. Diabetol. 20(1), 151 (2021).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"34196_CR12","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1038\/s41598-018-20866-4","volume":"8","author":"L Valls-Lacalle","year":"2018","unstructured":"Valls-Lacalle, L. et al. Selective inhibition of succinate dehydrogenase in reperfused myocardium with intracoronary malonate reduces infarct size. Sci. Rep. 8(1), 2442 (2018).","journal-title":"Sci. Rep."},{"key":"34196_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10557-020-07033-6","volume":"36","author":"HA Prag","year":"2020","unstructured":"Prag, H. A. et al. Ester prodrugs of malonate with enhanced intracellular delivery protect against cardiac ischemia-reperfusion injury in vivo. Cardiovasc. Drugs Ther. 36, 1\u201313. https:\/\/doi.org\/10.1007\/s10557-020-07033-6 (2020).","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"1","key":"34196_CR14","doi-asserted-by":"publisher","first-page":"10344","DOI":"10.1038\/s41598-020-67247-4","volume":"10","author":"NR Jespersen","year":"2020","unstructured":"Jespersen, N. R. et al. Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus. Sci. Rep. 10(1), 10344 (2020).","journal-title":"Sci. Rep."},{"issue":"2","key":"34196_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/cvr\/cvq205","volume":"88","author":"NB Stottrup","year":"2010","unstructured":"Stottrup, N. B. et al. Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection. Cardiovasc. Res. 88(2), 257\u2013266 (2010).","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"34196_CR16","doi-asserted-by":"publisher","first-page":"11742","DOI":"10.1038\/s41598-019-48227-9","volume":"9","author":"A Surendran","year":"2019","unstructured":"Surendran, A., Aliani, M. & Ravandi, A. Metabolomic characterization of myocardial ischemia-reperfusion injury in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. Sci. Rep. 9(1), 11742 (2019).","journal-title":"Sci. Rep."},{"issue":"2","key":"34196_CR17","doi-asserted-by":"publisher","first-page":"e4738","DOI":"10.1002\/bmc.4738","volume":"34","author":"G Gundogdu","year":"2020","unstructured":"Gundogdu, G. et al. Serum metabolite profiling of ST-segment elevation myocardial infarction using liquid chromatography quadrupole time-of-flight mass spectrometry. Biomed. Chromatogr. 34(2), e4738 (2020).","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"34196_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1148\/radiol.12111769","volume":"265","author":"P Croisille","year":"2012","unstructured":"Croisille, P., Kim, H. W. & Kim, R. J. Controversies in cardiovascular MR imaging: T2-weighted imaging should not be used to delineate the area at risk in ischemic myocardial injury. Radiology 265(1), 12\u201322 (2012).","journal-title":"Radiology"},{"issue":"14","key":"34196_CR19","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1161\/CIRCULATIONAHA.116.025582","volume":"136","author":"R Fernandez-Jimenez","year":"2017","unstructured":"Fernandez-Jimenez, R. et al. Dynamic edematous response of the human heart to myocardial infarction: Implications for assessing myocardial area at risk and salvage. Circulation 136(14), 1288\u20131300 (2017).","journal-title":"Circulation"},{"issue":"11","key":"34196_CR20","first-page":"1209","volume":"20","author":"N Sadagopan","year":"2007","unstructured":"Sadagopan, N. et al. Circulating succinate is elevated in rodent models of hypertension and metabolic disease. Am. J. Hypertens. 20(11), 1209\u20131215 (2007).","journal-title":"Am. J. Hypertens."},{"key":"34196_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12964-014-0078-2","volume":"12","author":"CJ Aguiar","year":"2014","unstructured":"Aguiar, C. J. et al. Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation. Cell Commun. Signal. 12, 78 (2014).","journal-title":"Cell Commun. Signal."},{"issue":"3","key":"34196_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/TA.0000000000001565","volume":"83","author":"A D'Alessandro","year":"2017","unstructured":"D\u2019Alessandro, A. et al. Plasma succinate is a predictor of mortality in critically injured patients. J. Trauma Acute Care Surg. 83(3), 491\u2013495 (2017).","journal-title":"J. Trauma Acute Care Surg."},{"issue":"42","key":"34196_CR23","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1093\/eurheartj\/ehab605","volume":"42","author":"H Cui","year":"2021","unstructured":"Cui, H. et al. Untargeted metabolomics identifies succinate as a biomarker and therapeutic target in aortic aneurysm and dissection. Eur. Heart J. 42(42), 4373\u20134385 (2021).","journal-title":"Eur. Heart J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34196-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34196-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34196-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T15:04:36Z","timestamp":1682607876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34196-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34196"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34196-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"assertion":[{"value":"5 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6907"}}